Feedback

We invite you to complete our short survey (2-3 minutes) on your experience of our website.

Latest

Pregnancy Appeal
George's Story

For years George had known his white blood cell count was too high, but as it was just outside the normal range. After being referred to Professor Baker, George was diagnosed with chronic lymphocytic leukaemia (CLL). He joined a clinical trial in August 2015 and two years later, George was completely free of CLL and leading a normal lifestyle.
Clinical Research Fellowship

The Perth Blood Institute (PBI) conducts medical research into blood disorders, including their causes, prevention and treatment options; facilitates access to high quality clinical trials for people affected by blood disorders; and provides information about blood disorders to patients and their families.
Feedback

Accessibility
COVID-19 and Thrombosis

The International Society of Thrombosis and Haemostasis has released information on COVID-19 and thrombosis. Here are the important facts; Having a blood clot does not increase your risk of acquiring COVID-19. Taking anticoagulants (blood-thinning medication) for a blood clot disorder also does not increase your risk of acquiring COVID-19.
Elie's Story

When Elie was a young, fit and healthy 22-year-old he noticed a lump in the side of his neck. He went to his GP complaining of fatigue, insomnia, and severe itching. After being misdiagnosed with glandular fever and then a mystery virus, he received a call from his doctor.
Privacy Policy

THE PERTH BLOOD INSTITUTE LIMITED ABN: 24164941815 (trading as Perth Blood Institute) takes your privacy seriously. We respect and uphold your right to privacy protection under the Australian Privacy Principles (APPs), by regulating the way in which we collect, use, disclose, hold and destroy your personal information. This Privacy Policy covers all personal information held by us.
Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.
Clinical Research Fellowship

The Perth Blood Institute (PBI) conducts medical research into blood disorders, including their causes, prevention and treatment options; facilitates access to high quality clinical trials for people affected by blood disorders; and provides information about blood disorders to patients and their families.
COVID-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them.
George's Story

For years George had known his white blood cell count was too high, but as it was just outside the normal range. After being referred to Professor Baker, George was diagnosed with chronic lymphocytic leukaemia (CLL). He joined a clinical trial in August 2015 and two years later, George was completely free of CLL and leading a normal lifestyle.
Understanding platelet dysfunction in Chronic Lymphocytic Leukemia

This project aims to examine platelets from healthy and Chronic Lymphocytic Leukemia (CLL) individuals to better understand the mechanisms underpinning platelet dysfunction in CLL, which may lead to better anti-cancer treatment strategies.
Key staff

Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists. Read more

Donate Fundraise